| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |